▶ 調査レポート

変形性関節症薬の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Drugs for Osteoarthritis Pain Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。変形性関節症薬の世界市場 2020年:企業別、地域別、種類・用途別 / Global Drugs for Osteoarthritis Pain Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-15819資料のイメージです。• レポートコード:D0804-15819
• 出版社/出版日:GlobalInfoResearch / 2020年7月
• レポート形態:英文、PDF、123ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
  Corporate User¥723,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、変形性関節症薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性関節症薬の種類別市場規模(経口、注射、外用)、用途別市場規模(医療、パーソナルケア)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Horizon Pharma、Bayer、Johnson & Johnson、Sanofi、GlaxoSmithKline、Mylan、Novartis、Eli Lilly、Abbott、Tide Pharmaceutical、Abiogen Pharma、Daiichi Sankyo、Iroko Pharmaceuticals、Astellas Pharma、TEVA、Hengrui Pharmaceutical、Almatica Pharma
・地域別グローバル市場分析 2015年-2020年
・変形性関節症薬の北米市場(アメリカ、カナダ、メキシコ)
・変形性関節症薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・変形性関節症薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・変形性関節症薬の南米市場(ブラジル、アルゼンチン)
・変形性関節症薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:経口、注射、外用
・用途別分析:医療、パーソナルケア
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Drugs for Osteoarthritis Pain sales will be xx in 2020 from Drugs for Osteoarthritis Pain million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Drugs for Osteoarthritis Pain market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Drugs for Osteoarthritis Pain industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Drugs for Osteoarthritis Pain and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Drugs for Osteoarthritis Pain market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Drugs for Osteoarthritis Pain market has been segmented into:
Oral
Injection
External

By Application, Drugs for Osteoarthritis Pain has been segmented into:
Medical Care
Personal Care

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Osteoarthritis Pain market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Osteoarthritis Pain markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Osteoarthritis Pain market.

The report offers in-depth assessment of the growth and other aspects of the Drugs for Osteoarthritis Pain market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Drugs for Osteoarthritis Pain Market Share Analysis
Drugs for Osteoarthritis Pain competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Osteoarthritis Pain sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Osteoarthritis Pain sales, revenue and market share for each player covered in this report.

The major players covered in Drugs for Osteoarthritis Pain are:
Pfizer
Horizon Pharma
Bayer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Mylan
Novartis
Eli Lilly
Abbott
Tide Pharmaceutical
Abiogen Pharma
Daiichi Sankyo
Iroko Pharmaceuticals
Astellas Pharma
TEVA
Hengrui Pharmaceutical
Almatica Pharma

レポート目次

1 Drugs for Osteoarthritis Pain Market Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain by Type
1.2.1 Global Drugs for Osteoarthritis Pain Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injection
1.2.5 External
1.3 Global Drugs for Osteoarthritis Pain Market by Application
1.3.1 Overview: Global Drugs for Osteoarthritis Pain Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Drugs for Osteoarthritis Pain Market by Regions
1.4.1 Global Drugs for Osteoarthritis Pain Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drugs for Osteoarthritis Pain (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drugs for Osteoarthritis Pain Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drugs for Osteoarthritis Pain Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Osteoarthritis Pain Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drugs for Osteoarthritis Pain Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Osteoarthritis Pain Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Drugs for Osteoarthritis Pain Industry Impact
1.5.1 COVID-19 Potential Implications for the Drugs for Osteoarthritis Pain
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Drugs for Osteoarthritis Pain
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly SWOT Analysis
2.9.4 Eli Lilly Product and Services
2.9.5 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.11 Tide Pharmaceutical
2.11.1 Tide Pharmaceutical Details
2.11.2 Tide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Tide Pharmaceutical SWOT Analysis
2.11.4 Tide Pharmaceutical Product and Services
2.11.5 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.12 Abiogen Pharma
2.12.1 Abiogen Pharma Details
2.12.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Abiogen Pharma SWOT Analysis
2.12.4 Abiogen Pharma Product and Services
2.12.5 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Daiichi Sankyo SWOT Analysis
2.13.4 Daiichi Sankyo Product and Services
2.13.5 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.14 Iroko Pharmaceuticals
2.14.1 Iroko Pharmaceuticals Details
2.14.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Iroko Pharmaceuticals SWOT Analysis
2.14.4 Iroko Pharmaceuticals Product and Services
2.14.5 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.15 Astellas Pharma
2.15.1 Astellas Pharma Details
2.15.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Astellas Pharma SWOT Analysis
2.15.4 Astellas Pharma Product and Services
2.15.5 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.16 TEVA
2.16.1 TEVA Details
2.16.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 TEVA SWOT Analysis
2.16.4 TEVA Product and Services
2.16.5 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hengrui Pharmaceutical SWOT Analysis
2.17.4 Hengrui Pharmaceutical Product and Services
2.17.5 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
2.18 Almatica Pharma
2.18.1 Almatica Pharma Details
2.18.2 Almatica Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Almatica Pharma SWOT Analysis
2.18.4 Almatica Pharma Product and Services
2.18.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drugs for Osteoarthritis Pain Players Market Share
3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions
4.2 North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
4.3 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
4.5 South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
5 North America Drugs for Osteoarthritis Pain Revenue by Countries
5.1 North America Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
5.2 USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
5.3 Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
5.4 Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
6 Europe Drugs for Osteoarthritis Pain Revenue by Countries
6.1 Europe Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
6.2 Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
6.3 UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
6.4 France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
6.5 Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
6.6 Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries
7.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
7.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
7.3 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
7.4 Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
7.5 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
8 South America Drugs for Osteoarthritis Pain Revenue by Countries
8.1 South America Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
8.2 Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
8.3 Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drugs for Osteoarthritis Pain by Countries
9.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
9.3 UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
9.4 Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
9.5 South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2015-2020)
10.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
10.5 External Revenue Growth Rate (2015-2025)
11 Global Drugs for Osteoarthritis Pain Market Segment by Application
11.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2015-2020)
11.2 Drugs for Osteoarthritis Pain Market Forecast by Application (2019-2024)
11.3 Medical Care Revenue Growth (2015-2020)
11.4 Personal Care Revenue Growth (2015-2020)
12 Global Drugs for Osteoarthritis Pain Market Size Forecast (2021-2025)
12.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2021-2025)
12.2 Global Drugs for Osteoarthritis Pain Market Forecast by Regions (2021-2025)
12.3 North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
12.4 Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
12.6 South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Drugs for Osteoarthritis Pain Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Pfizer Corporate Information, Location and Competitors
Table 7. Pfizer Drugs for Osteoarthritis Pain Major Business
Table 8. Pfizer Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 9. Pfizer SWOT Analysis
Table 10. Pfizer Drugs for Osteoarthritis Pain Product and Solutions
Table 11. Pfizer Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Horizon Pharma Corporate Information, Location and Competitors
Table 13. Horizon Pharma Drugs for Osteoarthritis Pain Major Business
Table 14. Horizon Pharma Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 15. Horizon Pharma SWOT Analysis
Table 16. Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 17. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bayer Corporate Information, Location and Competitors
Table 19. Bayer Drugs for Osteoarthritis Pain Major Business
Table 20. Bayer Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 21. Bayer SWOT Analysis
Table 22. Bayer Drugs for Osteoarthritis Pain Product and Solutions
Table 23. Bayer Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Johnson & Johnson Corporate Information, Location and Competitors
Table 25. Johnson & Johnson Drugs for Osteoarthritis Pain Major Business
Table 26. Johnson & Johnson Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 27. Johnson & Johnson SWOT Analysis
Table 28. Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions
Table 29. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Sanofi Corporate Information, Location and Competitors
Table 31. Sanofi Drugs for Osteoarthritis Pain Major Business
Table 32. Sanofi Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 33. Sanofi SWOT Analysis
Table 34. Sanofi Drugs for Osteoarthritis Pain Product and Solutions
Table 35. Sanofi Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. GlaxoSmithKline Corporate Information, Location and Competitors
Table 37. GlaxoSmithKline Drugs for Osteoarthritis Pain Major Business
Table 38. GlaxoSmithKline Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 39. GlaxoSmithKline SWOT Analysis
Table 40. GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions
Table 41. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Mylan Corporate Information, Location and Competitors
Table 43. Mylan Drugs for Osteoarthritis Pain Major Business
Table 44. Mylan Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 45. Mylan SWOT Analysis
Table 46. Mylan Drugs for Osteoarthritis Pain Product and Solutions
Table 47. Mylan Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Novartis Corporate Information, Location and Competitors
Table 49. Novartis Drugs for Osteoarthritis Pain Major Business
Table 50. Novartis Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 51. Novartis SWOT Analysis
Table 52. Novartis Drugs for Osteoarthritis Pain Product and Solutions
Table 53. Novartis Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Eli Lilly Corporate Information, Location and Competitors
Table 55. Eli Lilly Drugs for Osteoarthritis Pain Major Business
Table 56. Eli Lilly Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 57. Eli Lilly SWOT Analysis
Table 58. Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions
Table 59. Eli Lilly Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Abbott Corporate Information, Location and Competitors
Table 61. Abbott Drugs for Osteoarthritis Pain Major Business
Table 62. Abbott Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 63. Abbott SWOT Analysis
Table 64. Abbott Drugs for Osteoarthritis Pain Product and Solutions
Table 65. Abbott Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Tide Pharmaceutical Corporate Information, Location and Competitors
Table 67. Tide Pharmaceutical Drugs for Osteoarthritis Pain Major Business
Table 68. Tide Pharmaceutical Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 69. Tide Pharmaceutical SWOT Analysis
Table 70. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
Table 71. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Abiogen Pharma Corporate Information, Location and Competitors
Table 73. Abiogen Pharma Drugs for Osteoarthritis Pain Major Business
Table 74. Abiogen Pharma Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 75. Abiogen Pharma SWOT Analysis
Table 76. Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 77. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Daiichi Sankyo Corporate Information, Location and Competitors
Table 79. Daiichi Sankyo Drugs for Osteoarthritis Pain Major Business
Table 80. Daiichi Sankyo Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 81. Daiichi Sankyo SWOT Analysis
Table 82. Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions
Table 83. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Iroko Pharmaceuticals Corporate Information, Location and Competitors
Table 85. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Major Business
Table 86. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 87. Iroko Pharmaceuticals SWOT Analysis
Table 88. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions
Table 89. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Astellas Pharma Corporate Information, Location and Competitors
Table 91. Astellas Pharma Drugs for Osteoarthritis Pain Major Business
Table 92. Astellas Pharma Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 93. Astellas Pharma SWOT Analysis
Table 94. Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 95. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. TEVA Corporate Information, Location and Competitors
Table 97. TEVA Drugs for Osteoarthritis Pain Major Business
Table 98. TEVA Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 99. TEVA SWOT Analysis
Table 100. TEVA Drugs for Osteoarthritis Pain Product and Solutions
Table 101. TEVA Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Hengrui Pharmaceutical Corporate Information, Location and Competitors
Table 103. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Major Business
Table 104. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 105. Hengrui Pharmaceutical SWOT Analysis
Table 106. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
Table 107. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Almatica Pharma Drugs for Osteoarthritis Pain Type and Application
Table 109. Almatica Pharma Drugs for Osteoarthritis Pain Major Business
Table 110. Almatica Pharma Drugs for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 111. Almatica Pharma SWOT Analysis
Table 112. Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 113. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players (2015-2020)
Table 115. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2015-2020)
Table 116. Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions (2015-2020)
Table 118. North America Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
Table 119. North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 120. Europe Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Drugs for Osteoarthritis Pain Revenue by Countries (2015-2020)
Table 123. South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 126. Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Type (2015-2020)
Table 127. Global Drugs for Osteoarthritis Pain Revenue Share by Type (2015-2020)
Table 128. Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2021-2025)
Table 129. Global Drugs for Osteoarthritis Pain Revenue by Application (2015-2020)
Table 130. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2015-2020)
Table 131. Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2021-2025)
Table 132. Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Picture
Figure 2. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. External Picture
Figure 6. Drugs for Osteoarthritis Pain Revenue Market Share by Application in 2019
Figure 7. Medical Care Picture
Figure 8. Personal Care Picture
Figure 9. Global Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2019
Figure 18. Global Top 10 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions (2015-2020)
Figure 22. Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions in 2018
Figure 23. North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 24. Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 26. South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 28. North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 29. North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 30. USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 31. Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 33. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 35. Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 36. UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 37. France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 38. Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 39. Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 42. China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 43. Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 44. Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 45. India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 47. South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 48. South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 49. Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 54. UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2015-2020)
Figure 57. Global Drugs for Osteoarthritis Pain Revenue Share by Type (2015-2020)
Figure 58. Global Drugs for Osteoarthritis Pain Revenue Share by Type in 2019
Figure 59. Global Drugs for Osteoarthritis Pain Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral Revenue Growth Rate (2015-2020)
Figure 61. Global Injection Revenue Growth Rate (2015-2020)
Figure 62. Global External Revenue Growth Rate (2015-2020)
Figure 63. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2015-2020)
Figure 64. Global Drugs for Osteoarthritis Pain Revenue Share by Application in 2019
Figure 65. Global Drugs for Osteoarthritis Pain Market Share Forecast by Application (2021-2025)
Figure 66. Global Medical Care Revenue Growth Rate (2015-2020)
Figure 67. Global Personal Care Revenue Growth Rate (2015-2020)
Figure 68. Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
Figure 72. Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
Figure 74. South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel